Gifford Bioscience Limited is a contract research organization (CRO) performing preclinical and discovery pharmacology services for biotech, pharma and academic investigators. The company originally began in 2008 as Invivopharm Inc, a CRO based on radiometric receptor pharmacology studies, and this continues as the core focus of the company. Our studies are performed in vitro in cell and membrane preparations and ex vivo in human and rodent tissues. Focused services and a deep experience with our assays assures clients of quick turnaround times and the highest quality results.
Andrew Gifford, Ph.D. - Chief Scientific Officer and Chairman
Andrew was previously a Senior Scientist in the radiopharmaceutical development program at Brookhaven National Laboratory, New York. As a Principal Investigator, he has been responsible for the preclinical development of a variety of radiolabelled drugs. Techniques employed in his academic laboratories were primarily radiolabeling chemistry, ligand binding and occupancy assays and tissue autoradiography. Andrew is a graduate of Imperial College, London and was awarded his PhD in Pharmacology by the University of St. Andrews. He is an author on 51 peer-reviewed publications. Selected publications
Mr Macer Gifford - Chief Executive Officer and Managing Director
Macer is a banker by profession. His career has spanned numerous senior roles, including Deputy Group CEO at Ahli United and Group Head of Regional Markets at Standard Chartered. Macer is a graduate of the London School of Economics and a Sloan Fellow of the London Business School.
Allison Liu, Ph.D., VP, Research Operations
Dr. Liu received a Ph.D. in genetics from Cold Spring Harbor and performed postdoctoral training in the area of neurodegeneration at Rockefeller University. She previously was a staff scientist in the Medical Department at Brookhaven National Laboratory.
Taking advantage of an EU grant, we recently relocated to modern laboratory space in the Birmingham Research Park, next to the University of Birmingham, U.K.. Our facilities include a variety of standard and specialized research equipment, tissue culture and a broad radioactive substances permit. We additionally have access to animal housing via the University and to fresh post-surgical human tissues via the Human Biomaterials Resource Centrer at the Birmingham Queen Elizabeth Hospital.
Visits to our laboratory are welcome.